West Pharmaceutical Services (WST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 1,839,900 | 1,717,400 | 1,599,100 | 1,509,100 | 1,399,800 |
| Cost of Goods | 1,234,200 | 1,172,000 | 1,086,200 | 1,007,700 | 944,000 |
| Gross Profit | 605,700 | 545,400 | 512,900 | 501,400 | 455,800 |
| Operating Expenses | 309,300 | 305,100 | 287,300 | 306,900 | 327,200 |
| Operating Income | 296,600 | 240,300 | 225,800 | 195,200 | 128,600 |
| Interest Expense | 8,500 | 8,400 | 7,800 | 8,100 | 14,100 |
| Other Income | 12,600 | 16,400 | 13,600 | 10,900 | 7,400 |
| Pre-tax Income | 300,700 | 248,300 | 231,600 | 198,000 | 121,900 |
| Income Tax | 59,000 | 41,400 | 80,900 | 54,400 | 26,300 |
| Net Income Continuous | 241,700 | 206,900 | 150,700 | 143,600 | 95,600 |
| Net Income | $241,700 | $206,900 | $150,700 | $143,600 | $95,600 |
| EPS Basic Total Ops | 3.27 | 2.80 | 2.04 | 1.96 | 1.33 |
| EPS Basic Continuous Ops | 3.27 | 2.80 | 2.04 | 1.96 | 1.33 |
| EPS Diluted Total Ops | 3.21 | 2.74 | 1.99 | 1.91 | 1.30 |
| EPS Diluted Continuous Ops | 3.21 | 2.74 | 1.99 | 1.91 | 1.30 |
| EPS Diluted Before Non-Recurring Items | 3.24 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $400,000 | $344,700 | $322,500 | $285,900 | $218,500 |